Grünenthal Boosts Pain Drug Portfolio
By
Grünenthal, an Aachen, Germany-headquartered research-based pharmaceutical company, has acquired Thar Pharmaceuticals, a Pittsburgh, Pennsylvania-based clinical-stage specialty pharmaceutical company, to expand its development portfolio for treating complex regional pain syndrome (CRPS).…
Hikma in Pact for Generic Respiratory Drug
By
Hikma Pharmaceuticals, an Amman, Jordan-headquartered pharmaceutical company, has signed a development and licensing agreement with Vectura, a Chippenham, UK-headquartered pharmaceutical company, for its generic respiratory-drug product, VR730 (salmeterol), a long…
Allergan Buys Chase in $125-Million Deal
By
Allergan has acquired Chase Pharmaceuticals, an Irvine, California-headquartered clinical-stage biopharmaceutical company focused on neurodegenerative disorders, for an upfront payment of $125 million (subject to certain adjustments) and additional potential regulatory…
J&J in Talks for Potential Swiss Firm Acquisition
By
Johnson & Johnson (J&J) has confirmed that is engaged in preliminary discussions with Actelion Pharmaceuticals, an Allschwil, Basel, Switzerland-headquartered biopharmaceutical company, regarding a potential transaction. Acetlion also confirmed that it…